Winslow, Evans & Crocker, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 845 filers reported holding NOVARTIS A G in Q2 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.

Quarter-by-quarter ownership
Winslow, Evans & Crocker, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2020$106,000
+34.2%
1,121
+22.2%
0.02%0.0%
Q3 2020$79,000
+88.1%
917
+92.6%
0.02%
+81.8%
Q2 2020$42,000
+5.0%
4760.0%0.01%
-15.4%
Q1 2020$40,000
-62.3%
476
-56.2%
0.01%
-51.9%
Q4 2019$106,000
+8.2%
1,0880.0%0.03%0.0%
Q3 2019$98,000
-3.9%
1,088
+0.4%
0.03%
-3.6%
Q2 2019$102,000
+6.2%
1,084
+11.8%
0.03%
+3.7%
Q1 2019$96,000
+84.6%
970
+67.8%
0.03%
+58.8%
Q4 2018$52,000
-3.7%
578
-3.7%
0.02%
+6.2%
Q3 2018$54,000
+17.4%
6000.0%0.02%
+14.3%
Q2 2018$46,000
-99.9%
6000.0%0.01%
-12.5%
Q1 2018$48,512,000
-3.7%
6000.0%0.02%0.0%
Q4 2017$50,378,000
-2.2%
6000.0%0.02%
-5.9%
Q3 2017$51,512,000
-27.6%
600
-29.6%
0.02%
-15.0%
Q2 2017$71,116,000
-20.3%
852
-29.1%
0.02%
-28.6%
Q1 2017$89,274,000
+2.0%
1,2020.0%0.03%
+3.7%
Q4 2016$87,554,000
-57.2%
1,202
-82.7%
0.03%
-6.9%
Q3 2016$204,352,000
+91.4%
6,962
+438.0%
0.03%
-9.4%
Q2 2016$106,770,000
+13.9%
1,2940.0%0.03%
+14.3%
Q1 2016$93,737,000
-21.8%
1,294
-7.2%
0.03%
-17.6%
Q4 2015$119,942,000
-16.2%
1,394
-10.5%
0.03%
-24.4%
Q3 2015$143,120,000
-6.6%
1,5580.0%0.04%
+4.7%
Q2 2015$153,216,000
+5.1%
1,558
+5.3%
0.04%
+4.9%
Q1 2015$145,846,000
-8.2%
1,480
-13.8%
0.04%
-8.9%
Q4 2014$158,820,000
-11.0%
1,716
-9.5%
0.04%
-11.8%
Q3 2014$178,378,000
+15.0%
1,896
+10.6%
0.05%0.0%
Q2 2014$155,168,000
+6.5%
1,7140.0%0.05%
+2.0%
Q1 2014$145,725,000
+95771.7%
1,714
-9.4%
0.05%
-3.8%
Q4 2013$152,0001,8910.05%
Other shareholders
NOVARTIS A G shareholders Q2 2014
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders